Evidence map›Paper›PMID 32188500›Full record

ArticleCritical care (London, England)2020

Risk factors for candidemia: a prospective matched case-control study.

Julien Poissy, Lauro Damonti, Anne Bignon, Nina Khanna, Matthias Von Kietzell, Katia Boggian, Dionysios Neofytos, Fanny Vuotto, Valérie Coiteux, Florent Artru and 11 more

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
2.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 176 citations in OpenAlex.

  1. Trial
  2. Impact of a pharmacist-led infectious disease support team on candidemia bundle adherence and 28-day mortality: a single-center retrospective cohort study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  3. Article
  4. Article
  5. Overview of Risk Factors and Diagnosis of Invasive Candidiasis.Journal of fungi (Basel, Switzerland) · 2026
    Review
  6. Article
  7. Article
  8. Clinical characteristics and risk factors of mortality in patients with candidemia: a four-year retrospective study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Candidemia in a tertiary hospital in Southern Brazil.Revista do Instituto de Medicina Tropical de Sao Paulo · 2026
    Article
  15. An update on clinically relevant, rare, and emergingClinical microbiology reviews · 2025
    Review
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 2 countries.

Julien PoissyCurrent affiliation : Univ. Lille, Inserm U1285, CHU Lille, Pôle de réanimation, NRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000, Lille, France.ORCID 0000-0001-6017-5353
Lauro DamontiInfectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
Anne BignonSurgical Intensive Care Unit, University Hospital of Lille, F-59000, Lille, France.
Nina KhannaDivision of Infectious Diseases and Hospital Epidemiology, University and University Hospital of Basel, Basel, Switzerland.
Matthias Von KietzellInfectious Diseases Department, Cantonal Hospital of Saint Gallen, St. Gallen, Switzerland.
Katia BoggianInfectious Diseases Department, Cantonal Hospital of Saint Gallen, St. Gallen, Switzerland.
Dionysios NeofytosTransplant Infectious Diseases Unit, University Hospitals of Geneva, Geneva, Switzerland.
Fanny VuottoInfectious Diseases Department, University Hospital of Lille, F-59000, Lille, France.
Valérie CoiteuxHematological Disorders Department, University Hospital and University of Lille, F-59000, Lille, France.
Florent ArtruDigestive Intensive Care Department, University Hospital and University of Lille, F-59000, Lille, France.
Stephan ZimmerliDepartment of Infectious Diseases Department, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Jean-Luc PaganiAdult Intensive Care Service, University Hospital and University of Lausanne, Lausanne, Switzerland.
Thierry CalandraInfectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
Boualem SendidInserm, U995-2 "Fungal Associated Invasive and Inflammatory Diseases", F-59000, Lille, France.
Daniel PoulainInserm, U995-2 "Fungal Associated Invasive and Inflammatory Diseases", F-59000, Lille, France.
Christian van DeldenTransplant Infectious Diseases Unit, University Hospitals of Geneva, Geneva, Switzerland.
Frédéric LamothInfectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
Oscar MarchettiInfectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
Pierre-Yves BochudInfectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, rue du Bugnon 46, CH-1011, Lausanne, Switzerland. Pierre-Yves.Bochud@chuv.ch.
FUNGINOS
Allfun French Study Groups
Université de Lille · FRUniversity Hospital of Lausanne · CHInserm · FRLille Inflammation Research International Center · FRUniversity of Bern · CHUniversity of St.Gallen · CHCentre Hospitalier Universitaire de Lille · FRHôpital de Morges · CHKantonsspital St. Gallen · CHUniversity Hospital of Bern · CHUniversity of Basel · CH

Funding

European Union's Seventh Framework Program HEALTH-2010-260338swiss national foundation 324730-144054 and 33IC30_179636
6 · The paper itself

Abstract

backgroundCandidemia is an opportunistic infection associated with high morbidity and mortality in patients hospitalized both inside and outside intensive care units (ICUs). Identification of patients at risk is crucial to ensure prompt antifungal therapy. We sought to assess risk factors for candidemia and death, both outside and inside ICUs.

methodsThis prospective multicenter matched case-control study involved six teaching hospitals in Switzerland and France. Cases were defined by positive blood cultures for Candida sp. Controls were matched to cases using the following criteria: age, hospitalization ward, hospitalization duration, and, when applicable, type of surgery. One to three controls were enrolled by case. Risk factors were analyzed by univariate and multivariate conditional regression models, as a basis for a new scoring system to predict candidemia.

resultsOne hundred ninety-two candidemic patients and 411 matched controls were included. Forty-four percent of included patients were hospitalized in ICUs, and 56% were hospitalized outside ICUs. Independent risk factors for candidemia in the ICU population included total parenteral nutrition, acute kidney injury, heart disease, prior septic shock, and exposure to aminoglycoside antibiotics. Independent risk factors for candidemia in the non-ICU population included central venous catheter, total parenteral nutrition, and exposure to glycopeptides and nitroimidazoles. The accuracy of the scores based on these risk factors is better in the ICU than in the non-ICU population. Independent risk factors for death in candidemic patients included septic shock, acute kidney injury, and the number of antibiotics to which patients were exposed before candidemia. DISCUSSION: While this study shows a role for known and novel risk factors for candidemia, it specifically highlights important differences in their distribution according to the hospital setting (ICU versus non-ICU).

conclusionThis study provides novel risk scores for candidemia accounting for the hospital setting and recent progress in patients' management strategies and fungal epidemiology.

Indexed as

AgedAntifungal AgentsCandidemiaCase-Control StudiesCentral Venous CathetersCross InfectionFemaleFranceHospitalizationHumansIntensive Care UnitsMaleMiddle AgedProspective StudiesRisk FactorsSwitzerlandAntifungal AgentsAntibioticsCandidemiaCentral venous catheterRisk factorsScoresTotal parenteral nutrition

Identifiers

PMID32188500
PMCPMC7081522
OpenAlexW3012605821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.